Effect of Polymer Hydrophilicity and Molar Mass on the Properties of the Protein in Protein-Polymer Conjugates: The Case of PPEylated Myoglobin.
Journal
Biomacromolecules
ISSN: 1526-4602
Titre abrégé: Biomacromolecules
Pays: United States
ID NLM: 100892849
Informations de publication
Date de publication:
10 05 2021
10 05 2021
Historique:
pubmed:
9
4
2021
medline:
22
6
2021
entrez:
8
4
2021
Statut:
ppublish
Résumé
Polyphosphoesters (PPEs), a versatile class of biodegradable and biocompatible polymers, have been proposed as alternatives to poly(ethylene glycol) (PEG), which is suspected to be responsible for anaphylactic reactions in some patients after the administration of PEGylated compounds, e.g., in the current Covid-19 vaccines. We present the synthesis and characterization of a novel set of protein-polymer conjugates using the model protein myoglobin and a set of PPEs with different hydrophilicity and molar mass. We report an extensive evaluation of the (bio)physical properties of the protein within the conjugates, studying its conformation, residual activity, and thermal stability by complementary techniques (UV-vis spectroscopy, nano-differential scanning calorimetry, and fluorometry). The data underline the systematic influence of polymer hydrophilicity on protein properties. The more hydrophobic polymers destabilize the protein, the more hydrophilic PPEs protect against thermally induced aggregation and proteolytic degradation. This basic study aims at guiding the design of future PPEylated drugs and protein conjugates.
Identifiants
pubmed: 33830737
doi: 10.1021/acs.biomac.1c00058
pmc: PMC8154264
doi:
Substances chimiques
COVID-19 Vaccines
0
Myoglobin
0
Polymers
0
Polyethylene Glycols
3WJQ0SDW1A
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1932-1943Références
Bioconjug Chem. 2011 May 18;22(5):976-86
pubmed: 21452890
J Pharmacol Toxicol Methods. 2020 Mar - Apr;102:106678
pubmed: 31981619
J Biotechnol. 2014 Jul 10;181:55-63
pubmed: 24709400
Biomacromolecules. 2019 Jan 14;20(1):222-230
pubmed: 30512933
Bioconjug Chem. 1993 Nov-Dec;4(6):568-9
pubmed: 8305527
Biophys J. 1995 May;68(5):2091-7
pubmed: 7612852
Biomacromolecules. 2020 Feb 10;21(2):349-355
pubmed: 31687811
Eur J Biochem. 2001 Oct;268(20):5439-48
pubmed: 11606207
Biophys Chem. 2014 Jan;185:25-31
pubmed: 24309207
Biomacromolecules. 2016 Jan 11;17(1):141-7
pubmed: 26568153
Angew Chem Int Ed Engl. 2010 Aug 23;49(36):6288-308
pubmed: 20648499
Polym Chem. 2019 Jan 28;10(4):434-454
pubmed: 31249635
Chem Commun (Camb). 2020 Feb 25;56(16):2415-2418
pubmed: 31994584
Biomacromolecules. 2018 Apr 9;19(4):1212-1222
pubmed: 29526096
Polymers (Basel). 2018 May 14;10(5):
pubmed: 30966561
Biophys J. 1992 Apr;61(4):921-35
pubmed: 19431826
Angew Chem Int Ed Engl. 2018 May 4;57(19):5548-5553
pubmed: 29479798
Crit Rev Biotechnol. 2001;21(4):219-32
pubmed: 11797908
Adv Drug Deliv Rev. 2010 Feb 17;62(2):272-82
pubmed: 20005271
Biomacromolecules. 2016 Oct 10;17(10):3338-3346
pubmed: 27618845
Nat Nanotechnol. 2016 Apr;11(4):372-7
pubmed: 26878141
Blood Transfus. 2010 Jun;8 Suppl 3:s59-68
pubmed: 20606751
J Agric Food Chem. 2003 Sep 10;51(19):5815-23
pubmed: 12952438
Toxicol Lett. 1998 Nov 23;100-101:387-91
pubmed: 10049169
Macromol Biosci. 2017 Oct;17(10):
pubmed: 27943530
Biochemistry. 2010 Jul 27;49(29):6052-63
pubmed: 20540498
J Pharm Sci. 2016 Feb;105(2):460-475
pubmed: 26869412
J Biol Chem. 1985 Sep 5;260(19):10458-60
pubmed: 4030754
Biomacromolecules. 2018 Apr 9;19(4):1130-1141
pubmed: 29514006
Curr Opin Chem Biol. 2015 Oct;28:181-93
pubmed: 26356631
Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15231-6
pubmed: 19706892
Macromol Biosci. 2020 Jun;20(6):e1900410
pubmed: 32285628
Br J Anaesth. 2021 Mar;126(3):e106-e108
pubmed: 33386124
J Mol Biol. 1974 Jul 5;86(3):665-84
pubmed: 4368360
Nano Lett. 2020 Jan 8;20(1):526-533
pubmed: 31789526
Science. 2015 Oct 23;350(6259):445-50
pubmed: 26359336
Biophys Chem. 2007 Mar;126(1-3):16-24
pubmed: 16781052
Bioconjug Chem. 2008 Jan;19(1):299-305
pubmed: 18020402